Patients with stage IIIA NSCLC who receive lobectomy have increased overall survival: Research

Links shared publicly online about this topic.

1,133
total visits

Patients with stage IIIA NSCLC who receive lobectomy have increased overall survival: Research

There's debate about the best treatment approach for patients with certain stages of non-small cell lung cancer, which accounts for about 80 percent of all lung cancers. Patients with early stages of NSCLC are typically treated with surgery, but those with stage IIIA present more of a challenge because they are such a diverse group.

View full resource at news-medical.net

Tags: Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Lung, Oncology, News